Cardiovascular Systems, Inc. (NASDAQ:CSII) tinted gains of +1.58% (+0.46 points) to US$29.56. The volume of 0.38 Million shares climbed down over an trading activity of 243.11 Million shares. EPS ratio determined by looking at last 12 month figures is -0.04. Over the same time span, the stock marked US$33.11 as its best level and the lowest price reached was US$20.58. The corporation has a market cap of US$976.07 Million.

Cardiovascular Systems, Inc. (NASDAQ:CSII)’s earnings per share has been growing at a 43.1 percent rate over the past 5 year when average revenue increase was noted as 20 percent. The return on equity ratio or ROE stands at -1 percent while most common profitability ratio return on investment (ROI) was -1.2 percent. The company’s institutional ownership is monitored at 84.1 percent. The company’s net profit margin has achieved the current level of -0.6 percent and possesses 81.8 percent gross margin.

Daily Analyst Recommendations

A number of key analysts, polled by FactSet, shared their views about the current stock momentum. The forecast of 2 surveyed investment analysts covering the stock advises investors to Buy stake in the company. At present, 0 analysts call it Sell, while 3 think it is Hold. Recently, analysts have updated the overall rating to 2.43. 1 analysts recommended Overweight these shares while 1 recommended Underweight, according to FactSet data.

AAC Holdings, Inc. (NYSE:AAC) is worth US$270.28 Million and has recently risen 1.58% to US$11.58. The latest exchange of 0.1 Million shares is below its average trading activity of 173.03 Million shares. The day began at US$11.4 but the price moved to US$11.4 at one point during the trading and finally capitulating to a session high of US$11.57. The stock tapped a 52-week high of US$13.06 while the mean 12-month price target for the shares is US$14.

Currently, the stock carries a price to earnings ratio of 0, a price to book ratio of 1.79, and a price to sales ratio of 0.84. For the past 5 years, the company’s revenue has grown 36.9%, while the company’s earnings per share has grown -64.6%. With an institutional ownership near 67.3%, it carries an earnings per share ratio of -0.71.

Inside Look At Analysts Reviews

Latest analyst recommendations could offer little help to investors. The stock is a Buy among 1 brokerage firms polled by Factset Research. At present, 0 analysts recommended Holding these shares while 0 recommended sell, according to FactSet data. 0 analysts call it Underweight, while 2 think it is Overweight. Recently, investment analysts covering the stock have updated the mean rating to 1.67.